Yuan et al. did not report whether MHCI levels in MC38 tumors were affected by PCSK9, but they found that PCSK9 inhibition did not alter MHCI levels in B16F10 melanoma cells (59), indicating that PCSK9 regulates MHCI levels in a tumor/cell type-specific manner. Here, PCSK9 is linked to melanoma.